FACT Act

State Children's Health Insurance Program (SCHIP)/PL111-3 Managed Care Reform Title VII, PHS act Appropriate Physician payment levels/systems Medical Records Confidentiality Deficit Reduction Act Children's Access to health insurance Immunizations H.R. 194/S. 958 MediKids Health Insurance Act of 2009 WIC national Immunizations program (administration) The Start Healthy, Stay Healthy Act Immunization Coding Issues Health Care Coverage Expansion and Quality Improvement Act Children's Access to Vision Improvement Act Pandemic Influenza Heath Information Technology/Electronic Health Records HRZ-ARRA Emergency Medical Services for Children' Act Reauthorization Injury Prevention HR 1932/S 999 Child Health Care Crisis Relief Act Preemie Act Pediatrics Disaster Preparedness Education Begins at Home Act Child Maltreatment Foster Care and Adoption Native American Child Health Genetic Nondiscrimination Resident Physician Shortage Reduction Act HR872/S 588 Stem Cell Research Improvement Act HR 881 Mercury Free Vaccines Act HR 2184 Enhanced Health Care Value For All Act HR 2584 High Need Physician Workforce Incentives Act S. 1576 Minority Health Improvement and Health Disparity Elimination Act S. 1695 Biologics Price Competition and Innovation Act HR 1246 Early Hearing and Detection and Intervention Family Smoking Prevention and Tobacco Control Act (PL 111-31) H.R. 3525/S. 467 FACT Act HR1378/S.456 Food Allergy and Anaphylaxis Management Act HR1548Pathway for Biosimilars Act H.R. 4296/S.2408 E-Meds Act HR 1028 Support 21 Act of 2009 S. 726/HR 1427 Promoting Innovation and Access to Life Saving Medicine Act S.819 Autism Treatment Acceleration Act of 2009 HR 1261 Youth Prevention and Tobacco Harm Reduction Act HR 1339 Children's Access to Reconstruction Evaluation and Surgery (CARES)Act S. 1551, Comprehensive TB Elimination Act HR 1210/S. 984 Arthritis Prevention Control and Cure Act of 2009 S.301 Physician Payments Sunshine Act S. 678 Juvenile Justice and Delinquency Prevention Reauthorization Act of 2009 Americans with Disabilities Act National Center on Health Statistics Child Nutrition Reauthorization Needle Exchange Ban National AIDS Strategy HR 1380/S. 1197 Josh Miller HEARTS Act S. 621 Congenital Heart Futures Act Juvenile Justice Accountability and Improvement Act Vaccine Barcoding Pediatric Drugs and Devices HR 3590 The Patient Protection and Affordable Care Act HR 3962 To provide affordable, quality health care for all Americans and reduce the growth in health care spending, and for other purposes Stop Act Reauthorization Dependent Coverage Tobacco cessation Medicaid coverage Medicaid coverage for juveniles leaving justice system Screening, brief intervention, and referral to treatment for mental health and substance abuse Catastrophic health plans for young adults Insurance discrimination against clinical trial participants Biosimilars and pediatric research Medical home in health reform University autism research Food and Drug Administration Amendments Act (PL 110-85) titles III, IV, V

Client expense: $74,075 · Firm income: Not reported

Government targets: Agency for Healthcare Research & Quality (AHRQ), Agriculture, Dept of (USDA), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Congressional Budget Office (CBO), Consumer Product Safety Commission (CPSC), Education, Dept of, Environmental Protection Agency (EPA), Federal Emergency Management Agency (FEMA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Homeland Security, Dept of (DHS), Indian Health Service, Labor, Dept of (DOL), Natl Highway Traffic Safety Administration (NHTSA), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), SENATE, Transportation, Dept of (DOT), Treasury, Dept of, White House Office

State Children's Health Insurance Program (SCHIP)/PL111-3 Veto Override Managed Care Reform Title VII, PHS act Appropriate Physician payment levels/systems Medical Records Confidentiality Deficit Reduction Act Children's Access to health insurance Immunizations H.R. 194/S. 958 MediKids Health Insurance Act of 2009 WIC national Immunizations program (administration) The Start Healthy, Stay Healthy Act Immunization Coding Issues Health Care Coverage Expansion and Quality Improvement Act Children's Access to Vision Improvement Act Pandemic Influenza Heath Information Technology/Electronic Health Records HRZ-ARRA Emergency Medical Services for Children' Act Reauthorization Injury Prevention HR 1932/S 999 Child Health Care Crisis Relief Act Preemie Act Pediatrics Disaster Preparedness Education Begins at Home Act Child Maltreatment Foster Care and Adoption Native American Child Health Genetic Nondiscrimination Resident Physician Shortage Reduction Act HR872/S 588 Stem Cell Research Improvement Act HR 881 Mercury Free Vaccines Act HR 2184 Enhanced Health Care Value For All Act HR 2584 High Need Physician Workforce Incentives Act S. 1576 Minority Health Improvement and Health Disparity Elimination Act S. 1695 Biologics Price Competition and Innovation Act HR 1246 Early Hearing and Detection and Intervention Family Smoking Prevention and Tobacco Control Act (PL 111-31) H.R. 3525/S. 467 FACT Act HR1378/S.456 Food Allergy and Anaphylaxis Management Act HR1548Pathway for Biosimilars Act H.R. 4296/S.2408 E-Meds Act HR 1028 Support 21 Act of 2009 S. 726/HR 1427 Promoting Innovation and Access to Life Saving Medicine Act S.819 Autism Treatment Acceleration Act of 2009 S. 579 Federal Tobacco Act of 2009 HR 1261 Youth Prevention and Tobacco Harm Reduction Act HR 1339 Children's Access to Reconstruction Evaluation and Surgery (CARES)Act S. 1551, Comprehensive TB Elimination Act HR 1210/S. 984 Arthritis Prevention Control and Cure Act of 2009 S.301 Physician Payments Sunshine Act S. 678 Juvenile Justice and Delinquency Prevention Reauthorization Act of 2009 H.R. 179 Community AIDS and Hepatitis Prevention Act Americans with Disabilities Act National Center on Health Statistics Child Nutrition Reauthorization Needle Exchange Ban National AIDS Strategy HR 1380/S. 1197 Josh Miller HEARTS Act S. 621 Congential Heart Futures Act Juvenile Justice Accountability and Improvement Act Vaccine Barcoding Pediatric Drugs and Devices

Client expense: $57,797 · Firm income: Not reported

Government targets: Agency for Healthcare Research & Quality (AHRQ), Agriculture, Dept of (USDA), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Congressional Budget Office (CBO), Consumer Product Safety Commission (CPSC), Education, Dept of, Environmental Protection Agency (EPA), Federal Emergency Management Agency (FEMA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Homeland Security, Dept of (DHS), Indian Health Service, Labor, Dept of (DOL), Natl Highway Traffic Safety Administration (NHTSA), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), SENATE, Transportation, Dept of (DOT), Treasury, Dept of, White House Office

Stem Cell Research Enhancement Act of 2009 HR 872, H.R. 873 S 487 National Institutes of Health Clinical Trials Registry National Children's Study Agency For Health Care Research and Quality HR 1549/S. 619 Preservation of Antibiotics of Medical Treatment Act Preemie Act HR 2184 Enhanced Health Care Value For All Act S. 353/HR 758Minority Health Improvement and Health Disparity Elimination Act HR 3525/S.467 FACT Act Pediatric Research Consortia Establishment Act Antimicrobial Resistance/Animal Drug User Fees Act HR 3697/S.2313 Strategies to Address Antimicrobial Resistance Act SCHIP Reauthorization

Client expense: $57,797 · Firm income: Not reported

Government targets: Agency for Healthcare Research & Quality (AHRQ), Agriculture, Dept of (USDA), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Congressional Budget Office (CBO), Consumer Product Safety Commission (CPSC), Education, Dept of, Environmental Protection Agency (EPA), Federal Emergency Management Agency (FEMA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Homeland Security, Dept of (DHS), Indian Health Service, Labor, Dept of (DOL), Natl Highway Traffic Safety Administration (NHTSA), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), SENATE, Transportation, Dept of (DOT), Treasury, Dept of, White House Office

State Children's Health Insurance Program (SCHIP)/PL111-3 Veto Override Managed Care Reform Title VII, PHS act H.R. 2357/S. 2522 MediKids Appropriate Physician payment levels/systems Medical Records Confidentiality Deficit Reduction Act Children's Access to health insurance Immunizations H.R. 194/S. 958 MediKids Health Insurance Act of 2009 WIC national Immunizations program (administration) The Start Healthy, Stay Healthy Act Immunization Coding Issues Health Care Coverage Expansion and Quality Improvement Act Children's Access to Vision Improvement Act Pandemic Influenza Heath Information Technology/Electronic Health Records HRZ-ARRA Emergency Medical Services for Children' Act Reauthorization Injury Prevention HR 1932/S 999 Child Health Care Crisis Relief Act Preemie Act Pediatrics Disaster Preparedness Education Begins at Home Act Child Maltreatment Foster Care and Adoption Native American Child Health Genetic Nondiscrimination Resident Physician Shortage Reduction Act HR872/S 588 Stem Cell Research Improvement Act HR 881 Mercury Free Vaccines Act HR 2184 Enhanced Health Care Value For All Act HR 2584 High Need Physician Workforce Incentives Act S. 1576 Minority Health Improvement and Health Disparity Elimination Act S. 1695 Biologics Price Competition and Innovation Act HR 1246 Early Hearing and Detection and Intervention HR 1256 Family Smoking Prevention and Tobacco Control Act H.R. 3525/S. 467 FACT Act HR1378/S.456 Food Allergy and Anaphylaxis Management Act HR1548Pathway for Biosimilars Act H.R. 4296/S.2408 E-Meds Act HR 1028 Support 21 Act of 2009 S. 726/HR 1427 Promoting Innovation and Access to Life Saving Medicine Act S.819 Autism Treatment Acceleration Act of 2009 S. 579 Federal Tobacco Act of 2009 HR 1261 Youth Prevention and Tobacco Harm Reduction Act HR 1339 Children's Access to Reconstruction Evaluation and Surgery (CARES)Act S. 1551, Comprehensive TB Elimination Act HR 1210/S. 984 Arthritis Prevention Control and Cure Act of 2009 S.301 Physician Payments Sunshine Act S. 678 Juvenile Justice and Delinquency Prevention Reauthorization Act of 2009 H.R. 179 Community AIDS and Hepatitis Prevention Act Americans with Disabilities Act National Center on Health Statistics Child Nutrition Reauthorization Needle Exchange Ban

Client expense: $106,699 · Firm income: Not reported

Government targets: Agency for Healthcare Research & Quality (AHRQ), Agriculture, Dept of (USDA), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Congressional Budget Office (CBO), Consumer Product Safety Commission (CPSC), Education, Dept of, Environmental Protection Agency (EPA), Federal Emergency Management Agency (FEMA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Homeland Security, Dept of (DHS), Indian Health Service, Labor, Dept of (DOL), Natl Highway Traffic Safety Administration (NHTSA), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), SENATE, Transportation, Dept of (DOT), Treasury, Dept of, White House Office

Stem Cell Research Enhancement Act of 2009 HR 872, H.R. 873 S 487 National Institutes of Health Clinical Trials Registry National Children's Study Agency For Health Care Research and Quality HR 1549/S. 619 Preservation of Antibiotics of Medical Treatment Act Preemie Act HR 2184 Enhanced Health Care Value For All Act S. 353/HR 758Minority Health Improvement and Health Disparity Elimination Act HR 3525/S.467 FACT Act Pediatric Research Consortia Establishment Act Antimicrobial Resistance/Animal Drug User Fees Act HR 3697/S.2313 Strategies to Address Antimicrobial Resistance Act SCHIP Reauthorization

Client expense: $106,699 · Firm income: Not reported

Government targets: Agency for Healthcare Research & Quality (AHRQ), Agriculture, Dept of (USDA), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Congressional Budget Office (CBO), Consumer Product Safety Commission (CPSC), Education, Dept of, Environmental Protection Agency (EPA), Federal Emergency Management Agency (FEMA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Homeland Security, Dept of (DHS), Indian Health Service, Labor, Dept of (DOL), Natl Highway Traffic Safety Administration (NHTSA), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), SENATE, Transportation, Dept of (DOT), Treasury, Dept of, White House Office

-H.R. 1424, "Paul Wellstone Mental Health and Addiction Equity Act of 2007," regarding amending section 712 of the Employee Retirement Income Security Act of 1974, section 2705 of the Public Health Service Act, and section 9812 of the Internal Revenue Code of 1986 to require equity in the provision of mental health and substance-related disorder benefits under group health plans; -H.R. 1494 / S. 830, "Pediatric Medical Device Safety and Improvement Act of 2007," regarding improving the process for the development of needed pediatric medical devices; -H.R. 1956, "Patient Protection and Innovative Biologic Medicines Act of 2007," regarding amending the public Health Service Act to provide for the approval of similar biological products; -H.R. 2193, "Animal Protection Accountability Improvement Act," regarding amending the Animal Welfare Act to increase the penalties for violations of such Act to prohibit the use of animals for marketing medical devices; -H.R. 2349/ S. 1413, "Uterine Fibroid Research and Education Act of 2007," regarding providing for research and education with respect to uterine fibroids; -H.R. 3333 / S. 1576, "Minority Health Improvement and Health Disparity Elimination Act," regarding amending the Public Health Services Act to improve the health and healthcare of racial and ethnic minority groups; -H.R. 788 / S. 468, "Food and Drug Administration Safety Act of 2007," regarding amending the Federal Food, Drug, and Cosmetic Act with respect to drug safety; -H.R. 2900, "Food and Drug Administration Amendments Act of 2007," regarding amending the Federal Food, Drug, and Cosmetic Act to revise and extend the use-fee programs for prescription drugs and for medical devices and to enhance the postmarket authorities of the Food and Drug Administration with respect to the safety of drugs; -S. 1082, "Food and Drug Administration Revitalization Act," regarding amending the Federal Food, Drug, and Cosmetic Act and the Public Health Service Act to reauthorize drug and device user fees and ensure the safety of medical products; -S. 1695, "Biologics Price Competition and Innovation Act of 2007," regarding amending the Public Health Service Act to establish a pathway for the licensure of biosilimar products to promote innovation in the life sciences; -S. 467, "Fair Access to Clinical Trials Act of 2007 or the 'FACT Act'," regarding amending the Public Health Services Act to expand clinical trials drug data bank; -S. 558, "Mental Health Parity Act of 2007," regarding all provisions ; -S. 628, "Critical Access to Health Information Technology Act of 2007," regarding improving grants for rural health information technology development activities; -S. 993, "Pediatric Research Improvement Act," regarding improving pediatric research; issues regarding Acetemorphine and Phenelyperine; -H.R. 3580, "Food and Drug Administration Amendments Act of 2007," regarding fees related to prescription drugs, medical devices, and food safety; -H.R. 2419 / S. 2302, "Food and Energy Security Act of 2007," regarding marketing and financial assistance related to farming and food production; -H.R. 5606 / S. 2029, "Physician Payments Sunshine Act of 2007," regarding amending Title XI of the Social Security Act to provide for transparency in the relationship between physicians and manufacturers of drugs, devices, or medical supplies for which payment is made under Medicare, Medicaid, or SCHIP; -S. 2221, "Transparency in Medical Device Pricing Act of 2007," regarding amending Title XVIII of the Social Security Act to provide for the reporting of sales price data for implantable devices; -H.R. 3043, "Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2008," regarding appropriations for the Department of Health and Human Services; -H.R. 5629, "Pathway for Biosimilar Act," regarding amending the Public Health Service Act to establish a pathway for the licensure of biosimilar biological products; -H.R. 5839, "Safeguarding America's Pharmaceuticals Act of 2008", To Amend the Federal Food, Drug, and Cosmetic Act to improve the safety of drugs, regarding all provisions; -S. 334, "Healthy Americans Act", A bill to provide affordable, guaranteed private health coverage that will make Americans healthier and can never be taken away, regarding all provisions; -H.R. 6381, "Medical Device Safety Act of 2008", To amend the Federal Food, Drug, and Cosmetic Act with respect to liability under State and local requirements respecting devices, regarding all provisions; -S. 438, "Fair Prescription Drug Competition Act", A bill to amend the Federal Food, Drug, and Cosmetic Act to prohibit the marketing of authorized generic drugs, regarding all provisions; -S.2274, "A bill to amend the Controlled Substances Act to prevent the abuse of dextromethorphan", and for other purposes, regarding all provisions. -S.3409 "A bill to amend the Federal Food, Drug, and Cosmetic Act to ensure the safety and quality of medical products and enhance the authorities of the Food and Drug Administration", and for other purposes; regarding all provisions. -S.1378 "A bill to amend the Federal Food, Drug, and Cosmetic Act with respect to the distribution of the drug dextromethorphan", and for other purposes; regarding all provisions. -S. 3408, "Comparative Effectiveness Research Act of 2008", A bill to amend title XI of the Social Security Act to provide for the conduct of comparative effectiveness research and to amend the Internal Revenue Code of 1986 to establish a Comparative Effectiveness Research Trust Fund, and for other purposes, regarding all provisions; -S. 1276, "Methamphetamine Production Prevention Act of 2008", A bill to amend the Federal Food, Drug, and Cosmetic Act with respect to liability under State and local requirements respecting devices, regarding all provisions. -Proposed Rule (CMS-1403-P), Regarding revisions to Amendment of the E-Prescribing Exemption for Computer Generated Facsimile Transmissions; -S.2424, "A bill to ensure that all Americans have basic health literacy skills to function effectively as patients and health care consumers", regarding all provisions.

Client expense: $1,440,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

-H.R. 1424, "Paul Wellstone Mental Health and Addiction Equity Act of 2007," regarding amending section 712 of the Employee Retirement Income Security Act of 1974, section 2705 of the Public Health Service Act, and section 9812 of the Internal Revenue Code of 1986 to require equity in the provision of mental health and substance-related disorder benefits under group health plans; -H.R. 1494 / S. 830, "Pediatric Medical Device Safety and Improvement Act of 2007," regarding improving the process for the development of needed pediatric medical devices; -H.R. 1956, "Patient Protection and Innovative Biologic Medicines Act of 2007," regarding amending the public Health Service Act to provide for the approval of similar biological products; -H.R. 2193, "Animal Protection Accountability Improvement Act," regarding amending the Animal Welfare Act to increase the penalties for violations of such Act to prohibit the use of animals for marketing medical devices; -H.R. 2349/ S. 1413, "Uterine Fibroid Research and Education Act of 2007," regarding providing for research and education with respect to uterine fibroids; -H.R. 3333 / S. 1576, "Minority Health Improvement and Health Disparity Elimination Act," regarding amending the Public Health Services Act to improve the health and healthcare of racial and ethnic minority groups; -H.R. 788 / S. 468, "Food and Drug Administration Safety Act of 2007," regarding amending the Federal Food, Drug, and Cosmetic Act with respect to drug safety; -H.R. 2900, "Food and Drug Administration Amendments Act of 2007," regarding amending the Federal Food, Drug, and Cosmetic Act to revise and extend the use-fee programs for prescription drugs and for medical devices and to enhance the postmarket authorities of the Food and Drug Administration with respect to the safety of drugs; -S. 1082, "Food and Drug Administration Revitalization Act," regarding amending the Federal Food, Drug, and Cosmetic Act and the Public Health Service Act to reauthorize drug and device user fees and ensure the safety of medical products; -S. 1695, "Biologics Price Competition and Innovation Act of 2007," regarding amending the Public Health Service Act to establish a pathway for the licensure of biosilimar products to promote innovation in the life sciences; -S. 467, "Fair Access to Clinical Trials Act of 2007 or the 'FACT Act'," regarding amending the Public Health Services Act to expand clinical trials drug data bank; -S. 558, "Mental Health Parity Act of 2007," regarding all provisions ; -S. 628, "Critical Access to Health Information Technology Act of 2007," regarding improving grants for rural health information technology development activities; -S. 993, "Pediatric Research Improvement Act," regarding improving pediatric research; issues regarding Acetemorphine and Phenelyperine; -H.R. 3580, "Food and Drug Administration Amendments Act of 2007," regarding fees related to prescription drugs, medical devices, and food safety; -H.R. 2419 / S. 2302, "Food and Energy Security Act of 2007," regarding marketing and financial assistance related to farming and food production; -H.R. 5606 / S. 2029, "Physician Payments Sunshine Act of 2007," regarding amending Title XI of the Social Security Act to provide for transparency in the relationship between physicians and manufacturers of drugs, devices, or medical supplies for which payment is made under Medicare, Medicaid, or SCHIP; -S. 2221, "Transparency in Medical Device Pricing Act of 2007," regarding amending Title XVIII of the Social Security Act to provide for the reporting of sales price data for implantable devices; -H.R. 3043, "Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2008," regarding appropriations for the Department of Health and Human Services; -H.R. 5629, "Pathway for Biosimilar Act," regarding amending the Public Health Service Act to establish a pathway for the licensure of biosimilar biological products; -H.R. 5839, "Safeguarding America's Pharmaceuticals Act of 2008", To Amend the Federal Food, Drug, and Cosmetic Act to improve the safety of drugs, regarding all provisions; -S. 334, "Healthy Americans Act", A bill to provide affordable, guaranteed private health coverage that will make Americans healthier and can never be taken away, regarding all provisions; -H.R. 6381, "Medical Device Safety Act of 2008", To amend the Federal Food, Drug, and Cosmetic Act with respect to liability under State and local requirements respecting devices, regarding all provisions; -S. 438, "Fair Prescription Drug Competition Act", A bill to amend the Federal Food, Drug, and Cosmetic Act to prohibit the marketing of authorized generic drugs, regarding all provisions; -S.2274, "A bill to amend the Controlled Substances Act to prevent the abuse of dextromethorphan", and for other purposes, regarding all provisions. -S.3409 "A bill to amend the Federal Food, Drug, and Cosmetic Act to ensure the safety and quality of medical products and enhance the authorities of the Food and Drug Administration", and for other purposes; regarding all provisions. -S.1378 "A bill to amend the Federal Food, Drug, and Cosmetic Act with respect to the distribution of the drug dextromethorphan", and for other purposes; regarding all provisions. -S. 3408, "Comparative Effectiveness Research Act of 2008", A bill to amend title XI of the Social Security Act to provide for the conduct of comparative effectiveness research and to amend the Internal Revenue Code of 1986 to establish a Comparative Effectiveness Research Trust Fund, and for other purposes, regarding all provisions; -S. 1276, "Methamphetamine Production Prevention Act of 2008", A bill to amend the Federal Food, Drug, and Cosmetic Act with respect to liability under State and local requirements respecting devices, regarding all provisions. -Proposed Rule (CMS-1403-P), Regarding revisions to Amendment of the E-Prescribing Exemption for Computer Generated Facsimile Transmissions; -S.2424, "A bill to ensure that all Americans have basic health literacy skills to function effectively as patients and health care consumers", regarding all provisions.

Client expense: $1,440,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

-H.R. 1424, "Paul Wellstone Mental Health and Addiction Equity Act of 2007," regarding amending section 712 of the Employee Retirement Income Security Act of 1974, section 2705 of the Public Health Service Act, and section 9812 of the Internal Revenue Code of 1986 to require equity in the provision of mental health and substance-related disorder benefits under group health plans; -H.R. 1494 / S. 830, "Pediatric Medical Device Safety and Improvement Act of 2007," regarding improving the process for the development of needed pediatric medical devices; -H.R. 1956, "Patient Protection and Innovative Biologic Medicines Act of 2007," regarding amending the public Health Service Act to provide for the approval of similar biological products; -H.R. 2193, "Animal Protection Accountability Improvement Act," regarding amending the Animal Welfare Act to increase the penalties for violations of such Act to prohibit the use of animals for marketing medical devices; -H.R. 2349/ S. 1413, "Uterine Fibroid Research and Education Act of 2007," regarding providing for research and education with respect to uterine fibroids; -H.R. 3333 / S. 1576, "Minority Health Improvement and Health Disparity Elimination Act," regarding amending the Public Health Services Act to improve the health and healthcare of racial and ethnic minority groups; -H.R. 788 / S. 468, "Food and Drug Administration Safety Act of 2007," regarding amending the Federal Food, Drug, and Cosmetic Act with respect to drug safety; -H.R. 2900, "Food and Drug Administration Amendments Act of 2007," regarding amending the Federal Food, Drug, and Cosmetic Act to revise and extend the use-fee programs for prescription drugs and for medical devices and to enhance the postmarket authorities of the Food and Drug Administration with respect to the safety of drugs; -S. 1082, "Food and Drug Administration Revitalization Act," regarding amending the Federal Food, Drug, and Cosmetic Act and the Public Health Service Act to reauthorize drug and device user fees and ensure the safety of medical products; -S. 1695, "Biologics Price Competition and Innovation Act of 2007," regarding amending the Public Health Service Act to establish a pathway for the licensure of biosilimar products to promote innovation in the life sciences; -S. 467, "Fair Access to Clinical Trials Act of 2007 or the 'FACT Act'," regarding amending the Public Health Services Act to expand clinical trials drug data bank; -S. 558, "Mental Health Parity Act of 2007," regarding all provisions ; -S. 628, "Critical Access to Health Information Technology Act of 2007," regarding improving grants for rural health information technology development activities; -S. 993, "Pediatric Research Improvement Act," regarding improving pediatric research; issues regarding Acetemorphine and Phenelyperine; -H.R. 3580, "Food and Drug Administration Amendments Act of 2007," regarding fees related to prescription drugs, medical devices, and food safety; -H.R. 2419 / S. 2302, "Food and Energy Security Act of 2007," regarding marketing and financial assistance related to farming and food production; -H.R. 5606 / S. 2029, "Physician Payments Sunshine Act of 2007," regarding amending Title XI of the Social Security Act to provide for transparency in the relationship between physicians and manufacturers of drugs, devices, or medical supplies for which payment is made under Medicare, Medicaid, or SCHIP; -S. 2221, "Transparency in Medical Device Pricing Act of 2007," regarding amending Title XVIII of the Social Security Act to provide for the reporting of sales price data for implantable devices; -H.R. 3043, "Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2008," regarding appropriations for the Department of Health and Human Services; -H.R. 5629, "Pathway for Biosimilar Act," regarding amending the Public Health Service Act to establish a pathway for the licensure of biosimilar biological products; -H.R. 5839, "Safeguarding America's Pharmaceuticals Act of 2008", To Amend the Federal Food, Drug, and Cosmetic Act to improve the safety of drugs, regarding all provisions; -S. 334, "Healthy Americans Act", A bill to provide affordable, guaranteed private health coverage that will make Americans healthier and can never be taken away, regarding all provisions; -H.R. 6381, "Medical Device Safety Act of 2008", To amend the Federal Food, Drug, and Cosmetic Act with respect to liability under State and local requirements respecting devices, regarding all provisions; -S. 438, "Fair Prescription Drug Competition Act", A bill to amend the Federal Food, Drug, and Cosmetic Act to prohibit the marketing of authorized generic drugs, regarding all provisions; -S.2274, "A bill to amend the Controlled Substances Act to prevent the abuse of dextromethorphan", and for other purposes, regarding all provisions. -S.3409 "A bill to amend the Federal Food, Drug, and Cosmetic Act to ensure the safety and quality of medical products and enhance the authorities of the Food and Drug Administration", and for other purposes; regarding all provisions. -S.1378 "A bill to amend the Federal Food, Drug, and Cosmetic Act with respect to the distribution of the drug dextromethorphan", and for other purposes; regarding all provisions. -S. 3408, "Comparative Effectiveness Research Act of 2008", A bill to amend title XI of the Social Security Act to provide for the conduct of comparative effectiveness research and to amend the Internal Revenue Code of 1986 to establish a Comparative Effectiveness Research Trust Fund, and for other purposes, regarding all provisions; -S. 1276, "Methamphetamine Production Prevention Act of 2008", A bill to amend the Federal Food, Drug, and Cosmetic Act with respect to liability under State and local requirements respecting devices, regarding all provisions. -Proposed Rule (CMS-1403-P), Regarding revisions to Amendment of the E-Prescribing Exemption for Computer Generated Facsimile Transmissions; -S.2424, "A bill to ensure that all Americans have basic health literacy skills to function effectively as patients and health care consumers", regarding all provisions.

Client expense: $1,440,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

S 467 Terrorism Risk Insurance Extension Terrorism Insurance Backstop Extension Act

Client expense: Not reported · Firm income: $40,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

-H.R.1165, "Swift Approval, Full Evaluation Drug Act or the 'SAFE Drug Act," regarding amending the Federal Food, Drug, and Cosmetic Act to establish additional authorities to ensure the safe and effective use of drugs and to establish whistleblower protections for certain individuals; -H.R. 1424, "Paul Wellstone Mental Health and Addiction Equity Act of 2007," regarding amending section 712 of the Employee Retirement Income Security Act of 1974, section 2705 of the Public Health Service Act, and section 9812 of the Internal Revenue Code of 1986 to require equity in the provision of mental health and substance-related disorder benefits under group health plans; -H.R. 1494 / S. 830, "Pediatric Medical Device Safety and Improvement Act of 2007," regarding improving the process for the development of needed pediatric medical devices; -H.R. 1956, "Patient Protection and Innovative Biologic Medicines Act of 2007," regarding amending the public Health Service Act to provide for the approval of similar biological products; -H.R. 2193, "Animal Protection Accountability Improvement Act," regarding amending the Animal Welfare Act to increase the penalties for violations of such Act to prohibit the use of animals for marketing medical devices; -H.R. 2349/ S. 1413, "Uterine Fibroid Research and Education Act of 2007," regarding providing for research and education with respect to uterine fibroids; -H.R. 3333 / S. 1576, "Minority Health Improvement and Health Disparity Elimination Act," regarding amending the Public Health Services Act to improve the health and healthcare of racial and ethnic minority groups; -H.R. 788 / S. 468, "Food and Drug Administration Safety Act of 2007," regarding amending the Federal Food, Drug, and Cosmetic Act with respect to drug safety; -H.R. 2900, "Food and Drug Administration Amendments Act of 2007," regarding amending the Federal Food, Drug, and Cosmetic Act to revise and extend the use-fee programs for prescription drugs and for medical devices and to enhance the postmarket authorities of the Food and Drug Administration with respect to the safety of drugs; -S. 1082, "Food and Drug Administration Revitalization Act," regarding amending the Federal Food, Drug, and Cosmetic Act and the Public Health Service Act to reauthorize drug and device user fees and ensure the safety of medical products; -S. 1695, "Biologics Price Competition and Innovation Act of 2007," regarding amending the Public Health Service Act to establish a pathway for the licensure of biosilimar products to promote innovation in the life sciences; -S. 467, "Fair Access to Clinical Trials Act of 2007 or the 'FACT Act'," regarding amending the Public Health Services Act to expand clinical trials drug data bank; -S. 558, "Mental Health Parity Act of 2007," regarding all provisions ; -S. 628, "Critical Access to Health Information Technology Act of 2007," regarding improving grants for rural health information technology development activities; -S. 993, "Pediatric Research Improvement Act," regarding improving pediatric research; issues regarding Acetemorphine and Phenelyperine; -H.R. 3580, "Food and Drug Administration Amendments Act of 2007," regarding fees related to prescription drugs, medical devices, and food safety; -H.R. 2419 / S. 2302, "Food and Energy Security Act of 2007," regarding marketing and financial assistance related to farming and food production; -H.R. 5606 / S. 2029, "Physician Payments Sunshine Act of 2007," regarding amending Title XI of the Social Security Act to provide for transparency in the relationship between physicians and manufacturers of drugs, devices, or medical supplies for which payment is made under Medicare, Medicaid, or SCHIP; -S. 2221, "Transparency in Medical Device Pricing Act of 2007," regarding amending Title XVIII of the Social Security Act to provide for the reporting of sales price data for implantable devices; -H.R. 3043, "Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2008," regarding appropriations for the Department of Health and Human Services; -H.R. 5629, "Pathway for Biosimilar Act," regarding amending the Public Health Service Act to establish a pathway for the licensure of biosimilar biological products; -H.R. 5839, "Safeguarding America's Pharmaceuticals Act of 2008", To Amend the Federal Food, Drug, and Cosmetic Act to improve the safety of drugs, regarding all provisions; -S. 334, "Healthy Americans Act", A bill to provide affordable, guaranteed private health coverage that will make Americans healthier and can never be taken away, regarding all provisions; -H.R. 6381, "Medical Device Safety Act of 2008", To amend the Federal Food, Drug, and Cosmetic Act with respect to liability under State and local requirements respecting devices, regarding all provisions; -S. 438, "Fair Prescription Drug Competition Act", A bill to amend the Federal Food, Drug, and Cosmetic Act to prohibit the marketing of authorized generic drugs, regarding all provisions; -S. 3408, "Comparative Effectiveness Research Act of 2008", A bill to amend title XI of the Social Security Act to provide for the conduct of comparative effectiveness research and to amend the Internal Revenue Code of 1986 to establish a Comparative Effectiveness Research Trust Fund, and for other purposes, regarding all provisions; -S. 1276, "Methamphetamine Production Prevention Act of 2008", A bill to amend the Federal Food, Drug, and Cosmetic Act with respect to liability under State and local requirements respecting devices, regarding all provisions. -Proposed Rule (CMS-1403-P), Regarding revisions to Amendment of the E-Prescribing Exemption for Computer Generated Facsimile Transmissions;

Client expense: $1,500,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

CRE Lending Guidance New Basel Capital Accord Terrorism Risk Insurance - S. 467, H.R. 4314, H.R. 4513, H.R. 4619, H.R. 2761, H.R. 4299, S. 2285, H.Res. 660, H.Res.849 Natural Catastrophe Risk Insurance - S. 292, H.R. 537 Commission on Catastrophic Disaster Risk and Insurance Act - H.R. 3355, Homeowners Defense Act of 2007 Credit Crunch Federal Reserve Act Revisions HR 3122, Housing Bills

Client expense: $760,000 · Firm income: Not reported

Government targets: Army, Dept of (Corps of Engineers), Commerce, Dept of (DOC), Energy, Dept of, Environmental Protection Agency (EPA), Federal Communications Commission (FCC), Federal Reserve System, HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), Interior, Dept of (DOI), Justice, Dept of (DOJ), Labor, Dept of (DOL), Office of the Comptroller of the Currency (OCC), SENATE, Securities & Exchange Commission (SEC), Treasury, Dept of, White House Office

CRE Lending Guidance FASB Sarbanes Oxley Terrorism Risk Insurance S. 467, H.R. 4619, H.R. 2761, H.R. 4299, S. 2285, H. Res. 660, H. Res. 849 Natural Catastrophe R sk Insurance - S. 292, H.R. 537, H.R. 3355 FAS 140 - Servicer Discretion Credit Crunch Federal Reserve Act H.R. 3122, Housing Bill

Client expense: $760,000 · Firm income: Not reported

Government targets: Army, Dept of (Corps of Engineers), Commerce, Dept of (DOC), Energy, Dept of, Environmental Protection Agency (EPA), Federal Communications Commission (FCC), Federal Reserve System, HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), Interior, Dept of (DOI), Justice, Dept of (DOJ), Labor, Dept of (DOL), Office of the Comptroller of the Currency (OCC), SENATE, Securities & Exchange Commission (SEC), Treasury, Dept of, White House Office

S 467 Terrorism Risk Insurance Extension Terrorism Insurance Backstop Extension Act

Client expense: Not reported · Firm income: $50,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R.1165, "Swift Approval, Full Evaluation Drug Act or the 'SAFE Drug Act," regarding amending the Federal Food, Drug, and Cosmetic Act to establish additional authorities to ensure the safe and effective use of drugs and to establish whistleblower protections for certain individuals; H.R. 1424, "Paul Wellstone Mental Health and Addiction Equity Act of 2007," regarding amending section 712 of the Employee Retirement Income Security Act of 1974, section 2705 of the Public Health Service Act, and section 9812 of the Internal Revenue Code of 1986 to require equity in the provision o mental health and substance-related disorder benefits under group health plans; H.R. 1494 / S. 830, "Pediactric Medical Device Safety and Improvement Act of 2007," regarding improving the process for the development of needed pediactric medical devices; H.R. 1956, "Patient Protection and Innovative Biologic Medicines Act of 2007," regarding amending the public Health Service Act to provide for the approval of similar biological products; H.R. 2193, "Animal Protection Accountability Improvement Act," regarding amending the Animal Welfare Act to increase the penalties for violations of such Act to prohibit the use of animals for marketing medical devices; H.R. 2349/ S. 1413, "Uterine Fibroid Research and Education Act of 2007," regarding providing for research and education with respect to uterine fibroids; H.R. 3333 / S. 1576, "Minority Health Improvement and Health Disparity Elimination Act," regarding amending the Public Health Services Act to improve the health and healthcare of racial and ethnic minority groups; H.R. 788 / S. 468, "Food and Drug Administration Safety Act of 2007," regarding amending the Federal Food, Drug, and Cosmetic Act with respect to drug safety; H.R. 2900, "Food and Drug Administration Amendments Act of 2007," regarding amending the Federal Food, Drug, and Cosmetic Act to revise and extend the use-fee programs for prescription drugs and for medical devices and to enhance the postmarket authorities of the Food and Drug Administration with respect to the safety of drugs; S. 1082, "Food and Drug Administration Revitalization Act," regarding amending the Federal Food, Drug, and Cosmetic Act and the Public Health Service Act to reauthorize drug and device user fees and ensure the safety of medical products; S. 1695, "Biologics Price Competition and Innovation Act of 2007," regarding amending the Public Health Service Act to establish a pathway for the licensure of biosilimar products to promote innovation in the life sciences; S. 467, "Fair Access to Clinical Trials Act of 2007 or the 'FACT Act'," regarding amending the Public Health Services Act to expand clinical trials drug data bank; S. 558, "Mental Health Parity Act of 2007," regarding all provisions ; S. 628, "Critical Access to Health Information Technology Act of 2007," regarding improving grants for rural health information technology development activities; S. 993, "Pediatric Research Improvement Act," regarding improving pediatric research; issues regarding Acetemorphine and Phenelyperine; H.R. 3580, "Food and Drug Administration Amendments Act of 2007," regarding fees related to prescription drugs, medical devices, and food safety; H.R. 2419 / S. 2302, "Food and Energy Security Act of 2007," regarding marketing and financial assistance related to farming and food production; H.R. 5606 / S. 2029, "Physician Payments Sunshine Act of 2007," regarding amending Title XI of the Social Security Act to provide for transparency in the relationship between physicians and manufacturers of drugs, devices, or medical supplies for which payment is made under Medicare, Medicaid, or SCHIP; S. 2221, "Transparency in Medical Device Pricing Act of 2007," regarding amending Title XVIII of the Social Security Act to provide for the reporting of sales price data for implantable devices; H.R. 3043, "Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2008," regarding appropriations for the Department of Health and Human Services; H.R. 5629, "Pathway for Biosimilar Act," regarding amending the Public Health Service Act to establish a pathway for the licensure of biosimilar biological products; H.R. 5839, "To Amend the Federal Food, Drug, and Cosmetic Act to improve the safety of drugs", regarding all provisions; S. 334, "A bill to provide affordable, guaranteed private health coverage that will make Americans healthier and can never be taken away", regarding all provisions; H.R. 6381, "To amend the Federal Food, Drug, and Cosmetic Act with respect to liability under State and local requirements respecting devices", regarding all provisions; S. 438, "A bill to amend the Federal Food, Drug, and Cosmetic Act to prohibit the marketing of authorized generic drugs", regarding all provisions.

Client expense: $1,700,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE

H.R.1165, "Swift Approval, Full Evaluation Drug Act or the 'SAFE Drug Act," regarding amending the Federal Food, Drug, and Cosmetic Act to establish additional authorities to ensure the safe and effective use of drugs and to establish whistleblower protections for certain individuals; H.R. 1424, "Paul Wellstone Mental Health and Addiction Equity Act of 2007," regarding amending section 712 of the Employee Retirement Income Security Act of 1974, section 2705 of the Public Health Service Act, and section 9812 of the Internal Revenue Code of 1986 to require equity in the provision o mental health and substance-related disorder benefits under group health plans; H.R. 1494 / S. 830, "Pediactric Medical Device Safety and Improvement Act of 2007," regarding improving the process for the development of needed pediactric medical devices; H.R. 1956, "Patient Protection and Innovative Biologic Medicines Act of 2007," regarding amending the public Health Service Act to provide for the approval of similar biological products; H.R. 2193, "Animal Protection Accountability Improvement Act," regarding amending the Animal Welfare Act to increase the penalties for violations of such Act to prohibit the use of animals for marketing medical devices; H.R. 2349/ S. 1413, "Uterine Fibroid Research and Education Act of 2007," regarding providing for research and education with respect to uterine fibroids; H.R. 3333 / S. 1576, "Minority Health Improvement and Health Disparity Elimination Act," regarding amending the Public Health Services Act to improve the health and healthcare of racial and ethnic minority groups; H.R. 788 / S. 468, "Food and Drug Administration Safety Act of 2007," regarding amending the Federal Food, Drug, and Cosmetic Act with respect to drug safety; H.R. 2900, "Food and Drug Administration Amendments Act of 2007," regarding amending the Federal Food, Drug, and Cosmetic Act to revise and extend the use-fee programs for prescription drugs and for medical devices and to enhance the postmarket authorities of the Food and Drug Administration with respect to the safety of drugs; S. 1082, "Food and Drug Administration Revitalization Act," regarding amending the Federal Food, Drug, and Cosmetic Act and the Public Health Service Act to reauthorize drug and device user fees and ensure the safety of medical products; S. 1695, "Biologics Price Competition and Innovation Act of 2007," regarding amending the Public Health Service Act to establish a pathway for the licensure of biosilimar products to promote innovation in the life sciences; S. 467, "Fair Access to Clinical Trials Act of 2007 or the 'FACT Act'," regarding amending the Public Health Services Act to expand clinical trials drug data bank; S. 558, "Mental Health Parity Act of 2007," regarding all provisions ; S. 628, "Critical Access to Health Information Technology Act of 2007," regarding improving grants for rural health information technology development activities; S. 993, "Pediatric Research Improvement Act," regarding improving pediatric research; issues regarding Acetemorphine and Phenelyperine; H.R. 3580, "Food and Drug Administration Amendments Act of 2007," regarding fees related to prescription drugs, medical devices, and food safety; H.R. 2419 / S. 2302, "Food and Energy Security Act of 2007," regarding marketing and financial assistance related to farming and food production; H.R. 5606 / S. 2029, "Physician Payments Sunshine Act of 2007," regarding amending Title XI of the Social Security Act to provide for transparency in the relationship between physicians and manufacturers of drugs, devices, or medical supplies for which payment is made under Medicare, Medicaid, or SCHIP; S. 2221, "Transparency in Medical Device Pricing Act of 2007," regarding amending Title XVIII of the Social Security Act to provide for the reporting of sales price data for implantable devices; H.R. 3043, "Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2008," regarding appropriations for the Department of Health and Human Services; H.R. 5629, "Pathway for Biosimilar Act," regarding amending the Public Health Service Act to establish a pathway for the licensure of biosimilar biological products.

Client expense: $1,440,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE

S 467 Terrorism Risk Insurance Extension Terrorism Insurance Backstop Extension Act

Client expense: Not reported · Firm income: $30,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

CRE Lending Guidance FASB Sarbanes Oxley Terrorism Risk Insurance S. 467, H.R. 4619, H.R. 2761, H.R. 4299, S. 2285, H. Res. 660, H. Res. 849 Natural Catastrophe R sk Insurance - S. 292, H.R. 537, H.R. 3355 FAS 140 - Servicer Discretion Credit Crunch Federal Reserve Act

Client expense: $790,000 · Firm income: Not reported

Government targets: Army, Dept of (Corps of Engineers), Commerce, Dept of (DOC), Energy, Dept of, Environmental Protection Agency (EPA), Federal Communications Commission (FCC), Federal Reserve System, HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), Interior, Dept of (DOI), Justice, Dept of (DOJ), Labor, Dept of (DOL), Office of the Comptroller of the Currency (OCC), SENATE, Securities & Exchange Commission (SEC), Treasury, Dept of, White House Office

CRE Lending Guidance New Basel Capital Accord Terrorism Risk Insurance - S. 467, H.R. 4314, H.R. 4513, H.R. 4619, H.R. 2761, H.R. 4299, S. 2285, H.Res. 660, H.Res.849 Natural Catastrophe Risk Insurance - S. 292, H.R. 537 Commission on Catastrophic Disaster Risk and Insurance Act - H.R. 3355, Homeowners Defense Act of 2007 Credit Crunch Federal Reserve Act Revisions

Client expense: $790,000 · Firm income: Not reported

Government targets: Army, Dept of (Corps of Engineers), Commerce, Dept of (DOC), Energy, Dept of, Environmental Protection Agency (EPA), Federal Communications Commission (FCC), Federal Reserve System, HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), Interior, Dept of (DOI), Justice, Dept of (DOJ), Labor, Dept of (DOL), Office of the Comptroller of the Currency (OCC), SENATE, Securities & Exchange Commission (SEC), Treasury, Dept of, White House Office

SCHIP (Senate), Medicare cuts to finance SCHIP expansion H. R. 3162, CHAMP Act, Medicare cuts to finance SCHIP expansion S. 1376, 340B Program Improvement and Integrity Act of 2007, 340 B drug price expansion H. R. 2606, 340B Program Improvement and Integrity Act of 2007, 340 B drug price expansion S. 623, Access to Life-Saving Medicine Act, follow-on biologics H. R. 1038, Access to Life-Saving Medicine Act, follow-on biologics H. R. 1956, Patient Protection and Innovative Biologic Medicines Act of 2007, follow-on biologics S. 1505, Affordable Biologics for Consumers Act of 2007, follow-on biologics S. 1695, Biologics Price Competition and Innovation Act of 2007, follow-on biologics H. R. 1561, Enhancing Drug Safety and Innovation Act of 2007, PDUFA, drug safety provisions S. 1082, Prescription Drug User Fee Amendments of 2007, PDUFA, drug safety provisions H. R. 2900, Food and Drug Administration Amendments Act of 2007, PDUFA, drug safety provisions S. 467, FACT Act, clinical trials/drug safety provisions S. 596, Safe Internet Pharmacy Act of 2007, clinical trials/drug safety provisions S. 484, Enhancing Drug Safety and Innovation Act of 2007, clinical trials/drug safety provisions S. 993, Pediatric Research Improvement Act, clinical trials/drug safety provisions S. 1024, Safer DATA Act, clinical trials/drug safety provisions H. Con. Res. 99, Budget Resolution, drug importation, comparative effectiveness provisions S. Con. Res. 21, Budget Resolution, drug importation, comparative effectiveness provisions

Client expense: Not reported · Firm income: $120,000

Biogenetic Bill; PDUFA Reform; prescription drug safety; generic drugs; best buy drugs; comparative effectiveness; Medicare Part D; FDA drug safety; FDA reform; drug reimportation; HR 1561; S484; HR 4 S 1082; S467; S468; S424; HR 2184; HR 2090; S3807; S623

Client expense: $220,000 · Firm income: Not reported

Government targets: Agriculture, Dept of (USDA), Consumer Product Safety Commission (CPSC), Federal Communications Commission (FCC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Natl Highway Traffic Safety Administration (NHTSA), Office of the Comptroller of the Currency (OCC), SENATE, UNDETERMINED

Hospital infections; drug safety; drug cost; health information technology; Medicare Part D; Biogenetics;comparative effectiveness;S484;S3807; S467; S468; HR 2184

Client expense: $220,000 · Firm income: Not reported

Government targets: Agriculture, Dept of (USDA), Consumer Product Safety Commission (CPSC), Federal Communications Commission (FCC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Natl Highway Traffic Safety Administration (NHTSA), Office of the Comptroller of the Currency (OCC), SENATE, UNDETERMINED

Hospital infections; drug safety; drug cost; health information technology; Medicare Part D; Biogenetics;comparative effectiveness;S484;S3807; S467; S468; HR 2184

Client expense: $220,000 · Firm income: Not reported

Government targets: Agriculture, Dept of (USDA), Consumer Product Safety Commission (CPSC), Federal Communications Commission (FCC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Natl Highway Traffic Safety Administration (NHTSA), Office of the Comptroller of the Currency (OCC), SENATE, UNDETERMINED

Biogenetic Bill; PDUFA Reform; prescription drug safety; generic drugs; best buy drugs; comparative effectiveness; Medicare Part D; FDA drug safety; FDA reform; drug reimportation; HR 1561; S484; HR 4 S 1082; S467; S468; S424; HR 2184; HR 2090; S3807; S623

Client expense: $220,000 · Firm income: Not reported

Government targets: Agriculture, Dept of (USDA), Consumer Product Safety Commission (CPSC), Federal Communications Commission (FCC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Natl Highway Traffic Safety Administration (NHTSA), Office of the Comptroller of the Currency (OCC), SENATE, UNDETERMINED

Hospital infections; drug safety; drug cost; health information technology; Medicare Part D; Biogenetics;comparative effectiveness;S484;S3807; S467; S468; HR 2184

Client expense: $216,381 · Firm income: Not reported

Government targets: Agriculture, Dept of (USDA), Consumer Product Safety Commission (CPSC), Federal Communications Commission (FCC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Natl Highway Traffic Safety Administration (NHTSA), Office of the Comptroller of the Currency (OCC), SENATE, UNDETERMINED

Biogenetic Bill; PDUFA Reform; prescription drug safety; generic drugs; best buy drugs; comparative effectiveness; Medicare Part D; FDA drug safety; FDA reform; drug reimportation; HR 1561; S484; HR 4 S 1082; S467; S468; S424; HR 2184; HR 2090; S3807; S623

Client expense: $216,381 · Firm income: Not reported

Government targets: Agriculture, Dept of (USDA), Consumer Product Safety Commission (CPSC), Federal Communications Commission (FCC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Natl Highway Traffic Safety Administration (NHTSA), Office of the Comptroller of the Currency (OCC), SENATE, UNDETERMINED

H. R. 1038, Access to Life-Saving Medicine Act, follow-on biologics H. R. 1561, Enhancing Drug Safety and Innovation Act of 2007, PDUFA, drug safety provisions H. R. 1956, Patient Protection and Innovative Biologic Medicines Act of 2007, follow-on biologics H. R. 2638, Homeland Security Appropriations Act, drug importation provisions H. R. 2764, Foreign Operations and Related Programs Appropriations Act, 2008 H. R. 2900, Food and Drug Administration Amendments Act of 2007, PDUFA, drug safety provisions H. R. 3043, Labor-HHS-Education and Related Agencies Appropriations Act, diabetes research funding H. R. 3580, Food and Drug Administration Amendments Act of 2007 S. 1024, Safer DATA Act, clinical trials/drug safety provisions S. 1082, Prescription Drug User Fee Amendments of 2007, PDUFA, drug safety provisions S. 1505, Affordable Biologics for Consumers Act of 2007, follow-on biologics S. 1644, Homeland Security Appropriations Act, drug importation provisions S. 1695, Biologics Price Competition and Innovation Act of 2007, follow-on biologics S. 1710, Labor-HHS-Education and Related Agencies Appropriations Act, diabetes research funding S. 1745, Commerce, Justice, Science and Related Agencies Appropriations Act, DEA drug importation language S. 2029, Physician Payments Sunshine Act of 2007 S. 467, FACT Act, clinical trials/drug safety provisions S. 484, Enhancing Drug Safety and Innovation Act of 2007, clinical trials/drug safety provisions S. 596, Safe Internet Pharmacy Act of 2007, clinical trials/drug safety provisions S. 993, Pediatric Research Improvement Act, clinical trials/drug safety provisions S. 242, Pharmaceutical Market Access and Drug Safety Act of 2007, drug importation provisions S. 1156, Best Pharmaceuticals for Children Amendments of 2007, pediatric exclusivity provisions in FDARA/PDUFA bill S. 623, Access to Life-Saving Medicine Act, follow-on biologics

Client expense: Not reported · Firm income: $120,000

Government targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE

H. R. 1956, Patient Protection and Innovative Biologic Medicines Act of 2007, follow-on biologics H. R. 2900, Food and Drug Administration Amendments Act of 2007, PDUFA, drug safety provisions H. R. 3580, Food and Drug Administration Amendments Act of 2007 S. 1024, Safer DATA Act, clinical trials/drug safety provisions S. 1082, Prescription Drug User Fee Amendments of 2007, PDUFA, drug safety provisions S. 1156, Best Pharmaceuticals for Children Amendments of 2007, pediatric exclusivity provisions in FDARA/PDUFA bill S. 1505, Affordable Biologics for Consumers Act of 2007, follow-on biologics S. 1695, Biologics Price Competition and Innovation Act of 2007, follow-on biologics S. 2029, Physician Payments Sunshine Act of 2007 S. 242, Pharmaceutical Market Access and Drug Safety Act of 2007, drug importation provisions S. 4, Improving America's Security Act of 2007, cargo-screening provision S. 467, FACT Act, clinical trials/drug safety provisions S. 484, Enhancing Drug Safety and Innovation Act of 2007, clinical trials/drug safety provisions S. 596, Safe Internet Pharmacy Act of 2007, clinical trials/drug safety provisions S. 623, Access to Life-Saving Medicine Act, follow-on biologics S. 993, Pediatric Research Improvement Act, clinical trials/drug safety provisions H. R. 1, Implementing the 9/11 Commission Recommendations Act of 2007, cargo-screening provision H. R. 1038, Access to Life-Saving Medicine Act, follow-on biologics H. R. 1561, Enhancing Drug Safety and Innovation Act of 2007, PDUFA, drug safety provisions

Client expense: Not reported · Firm income: $80,000

Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

H. R. 2638, Homeland Security Appropriations Act, drug importation provisions H. R. 2764, Foreign Operations and Related Programs Appropriations Act, 2008, (Division A, Division G) H. R. 2900, Food and Drug Administration Revitalization Act, drug safety provisions H. R. 3093, Departments of Commerce and Justice, Science, and Related Agencies Appropriations Act, DEA drug importation language H.R. 3043, Labor, Heath/Human Services/Education/Related Agencies Appropriations Act, 2008 H.R. 3580, Food and Drug Administration Amendments Act of 2007 S. 1024, Safer DATA Act, clinical trials/drug safety provisions S. 1082, Prescription Drug User Fee Amendments of 2007, drug safety provisions S. 1156, Best Pharmaceuticals for Children Amendments of 2007, pediatric exclusivity provisions in FDARA/PDUFA bill S. 1505, Affordable Biologics for Consumers Act, follow-on biologics S. 1644, Homeland Security Appropriations Act, drug importation provisions S. 1695, Biologics Price Competition and Innovation Act of 2007, follow-on biologics S. 1710, Labor, Heath/Human Services/Education/Related Agencies Appropriations Act, 2008 S. 1745, Departments of Commerce and Justice, Science, and Related Agencies Appropriations Act, DEA drug importation language S. 2029, Physician Payments Sunshine Act of 2007 S. 242, Pharmaceutical Market Access and Drug Safety Act of 2007, drug importation provisions S. 467, FACT Act, clinical trials/drug safety provisions S. 484, Enhancing Drug Safety and Innovation Act of 2007, clinical trials/drug safety provisions S. 596, Safe Internet Pharmacy Act of 2007, clinical trials/drug safety provisions S. 623, Access to Life-Saving Medicine Act, follow-on biologics S. 993, Pediatric Research Improvement Act, clinical trials/drug safety provisions H. R. 1038, Access to Life-Saving Medicine Act, follow-on biologics H. R. 1561, Enhancing Drug Safety and Innovation Act of 2007, drug safety provisions H. R. 1956, Patient Protection and Innovative Biologic Medicines Act of 2007, follow-on biologics

Client expense: Not reported · Firm income: $80,000

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE

S 467 Terrorism Risk Insurance Extension

Client expense: Not reported · Firm income: $60,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H. R. 1038, Access to Life-Saving Medicine Act, follow-on biologics H. R. 1561, Enhancing Drug Safety and Innovation Act of 2007, PDUFA/drug safety H. R. 1956, Patient Protection and Innovative Biologic Medicines Act of 2007, follow-on biologics H. R. 2638, Homeland Security Appropriations Act, drug importation provisions H. R. 2764, Foreign Operations and Related Programs Appropriations Act, 2008, (Division A & G) H. R. 2900, Food and Drug Administration Revitalization Act, PDUFA/drug safety H. R. 3043, Labor-HHS-Education and Related Agencies Appropriations Act, Medicare, healthcare, and drug pricing provisions H. R. 3580, Food and Drug Administration Amendments Act of 2007 S. 1024, Safer DATA Act, clinical trials/drug safety provisions S. 1082, Prescription Drug User Fee Amendments of 2007, PDUFA/drug safety S. 1156, Best Pharmaceuticals for Children Amendmentsk, pediatric exclusivity provisions in FDARA/PDUFA bill S. 1505, Affordable Biologics for Consumers Act of 2007, follow-on biologics S. 1644, Homeland Security Appropriations Act, drug importation provisions S. 1695, Biologics Price Competition and Innovation Act of 2007, follow-on biologics S. 1710, Labor-HHS-Education and Related Agencies Appropriations Act, Medicare, healthcare, and drug pricing provisions S. 2029, Physician Payments Sunshine Act of 2007 S. 242, Pharmaceutical Market Access and Drug Safety Act of 2007, drug importation provisions S. 484, Enhancing Drug Safety and Innovation Act of 2007, clinical trials/drug safety provisions S. 596, Safe Internet Pharmacy Act of 2007, clinical trials/drug safety provisions S. 623, Access to Life-Saving Medicine Act, follow-on biologics S. 993, Pediatric Research Improvement Act, clinical trials/drug safety provisions H. R. 1585, National Defense Authorization Act, drug pricing provisions S. 1547, National Defense Authorization Act, drug pricing provisions S. 467, FACT Act, clinical trials/drug safety provisions

Client expense: Not reported · Firm income: $20,000

Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE

H. R. 1038, Access to Life-Saving Medicine Act, follow-on biologics H. R. 1561, Enhancing Drug Safety and Innovation Act of 2007, PDUFA and drug safety H. R. 1956, Patient Protection and Innovative Biologic Medicines Act of 2007, follow-on biologics H. R. 2764, Foreign Operations and Related Programs Appropriations Act, 2008, (Division A & G) H. R. 2900, Food and Drug Administration Amendments Act of 2007, PDUFA and drug safety H. R. 3043, Labor-HHS-Education and Related Agencies Appropriations Act, Medic H. R. 3580, Food and Drug Administration Amendments Act of 2007 S. 1024, Safer DATA Act, clinical trials and drug safety provisions S. 1082, Prescription Drug User Fee Amendments of 2007, PDUFA and drug safety S. 1156, Best Pharmaceuticals for Children Amendments of 2007, pediatric exclusivity provisions in FDARA/PDUFA bill S. 1505, Affordable Biologics for Consumers Act of 2007, follow-on biologics S. 1644, Homeland Security Appropriations Act, drug importation provisions S. 1695, Biologics Price Competition and Innovation Act of 2007, follow-on biologics S. 1710, Labor-HHS-Education and Related Agencies Appropriations Act, Medicare, healthcare, and drug pricing provisions S. 2029, Physician Payments Sunshine Act of 2007 S. 242, Pharmaceutical Market Access and Drug Safety Act of 2007, drug importation provisions S. 467, FACT Act, clinical trials and drug safety provisions S. 484, Enhancing Drug Safety and Innovation Act of 2007, clinical trials and drug safety provisions S. 596, Safe Internet Pharmacy Act of 2007, clinical trials and drug safety provisions S. 623, Access to Life-Saving Medicine Act, follow-on biologics S. 993, Pediatric Research Improvement Act, clinical trials and drug safety provisions S. 1745, Commerce, Justice, Science, and Related Agencies Appropriations Act, DEA drug importation language H. R. 2638, Homeland Security Appropriations Act, drug importation provisions

Client expense: Not reported · Firm income: $100,000

Government targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Patent & Trademark Office (PTO), SENATE

HR 1424, "Paul Wellstone Mental Health and Addiction Equity Act of 2007,” regarding amending section 712 of the Employee Retirement Income Security Act of 1974, section 2705 of the Public Health Service Act, and section 9812 of the Internal Revenue Code of 1986 to require equity in the provision of mental health and substance-related disorder benefits under group health plans; HR 1494 / S 830, “Pediatric Medical Device Safety and Improvement Act of 2007,” regarding improving the process for the development of needed pediatric medical devices; HR 1956, “Patient Protection and Innovative Biologic Medicines Act of 2007,” regarding amending the Public Health Service Act to provide for the approval of similar biological products; HR 2193, “Animal Protection Accountability Improvement Act,” regarding amending the Animal Welfare Act to increase the penalties for violations of such Act and to prohibit the use of animals for marketing medical devices; HR 2349 / S 1413, “Uterine Fibroid Research and Education Act of 2007,” regarding providing for research and education with respect to uterine fibroids; HR 3333 / S. 1576, “Minority Health Improvement and Health Disparity Elimination Act,” regarding amending the Public Health Service Act to improve the health and healthcare of racial and ethnic minority groups; HR 788 / S 468, “Food and Drug Administration Safety Act of 2007,” regarding amending the Federal Food, Drug, and Cosmetic Act with respect to drug safety; HR 2900, “Food and Drug Administration Amendments Act of 2007,” regarding amending the Federal Food, Drug, and Cosmetic Act to revise and extend the user-fee programs for prescription drugs and for medical devices and to enhance the postmarket authorities of the Food and Drug Administration with respect to the safety of drugs; S 1082, “Food and Drug Administration Revitalization Act,” regarding amending the Federal Food, Drug, and Cosmetic Act and the Public Health Service Act to reauthorize drug and device user fees and ensure the safety of medical products; S 1695, “Biologics Price Competition and Innovation Act of 2007,” regarding amending the Public Health Service Act to establish a pathway for the licensure of biosimilar biological products and to promote innovation in the life sciences; S 467, “Fair Access to Clinical Trials Act of 2007 or the `FACT Act',” regarding amending the Public Health Service Act to expand the clinical trials drug data bank; S 558, “Mental Health Parity Act of 2007,” regarding all provisions; S 628, “Critical Access to Health Information Technology Act of 2007,” regarding providing grants for rural health information technology development activities; S 993, “Pediatric Research Improvement Act,” regarding improving pediatric research; issues regarding Acetemorphine and Phenelyperine.   HR 1165, “Swift Approval, Full Evaluation Drug Act or the `SAFE Drug Act',” regarding amending the Federal Food, Drug, and Cosmetic Act to establish additional authorities to ensure the safe and effective use of drugs and to establish whistleblower protections for certain individuals;

Client expense: $3,820,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

H. R. 1038, Access to Life-Saving Medicine Act, follow-on biologics H. R. 1956, Patient Protection and Innovative Biologic Medicines Act of 2007, follow-on biologics S. 1505, Affordable Biologics for Consumers Act of 2007, follow-on biologics S. 1695, Biologics Price Competition and Innovation Act of 2007, follow-on biologics H. R. 1561, Enhancing Drug Safety and Innovation Act of 2007, PDUFA, drug safety provisions S. 1082, Prescription Drug User Fee Amendments of 2007, PDUFA, drug safety provisions H. R. 2900, Food and Drug Administration Amendments Act of 2007, PDUFA, drug safety provisions S. 467, FACT Act, clinical trials/drug safety provisions S. 596, Safe Internet Pharmacy Act of 2007, clinical trials/drug safety provisions S. 484, Enhancing Drug Safety and Innovation Act of 2007, clinical trials/drug safety provisions S. 993, Pediatric Research Improvement Act, clinical trials/drug safety provisions S. 1024, Safer DATA Act, clinical trials/drug safety provisions H. Con. Res. 99, Budget Resolution, drug importation, comparative effectiveness provisions S. Con. Res. 21, Budget Resolution, drug importation, comparative effectiveness provisions S. 1745, Commerce, Justice, Science and Related Agencies Appropriations Act, DEA drug importation language H. R. 2638, Homeland Security Appropriations Act, drug importation provisions S. 1644, Homeland Security Appropriations Act, drug importation provisions S. 242, Pharmaceutical Market Access and Drug Safety Act of 2007, drug importation provisions S. 1156, Best Pharmaceuticals for Children Amendments of 2007, pediatric exclusivity provisions in FDARA/PDUFA bill S. 623, Access to Life-Saving Medicine Act, follow-on biologics

Client expense: Not reported · Firm income: $100,000

Government targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE

Community Choice in Real Estate Act Terrorism Risk Insurance - S. 467, H.R. 4314, H.R. 4513, H.R. 4619 Natural Catastrophe Risk Insurance CRE Lending Guidance U.S. Financial Policy Committee for Fair Capital Standards Act - H.R. 2043 New Basel Capital Accord Bankruptcy Reform Legislation - S. 1559; H.R. 2815

Client expense: $1,283,630 · Firm income: Not reported

Government targets: Army, Dept of (Corps of Engineers), Environmental Protection Agency (EPA), Federal Communications Commission (FCC), Federal Reserve System, HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), Interior, Dept of (DOI), Justice, Dept of (DOJ), Labor, Dept of (DOL), SENATE, Treasury, Dept of, White House Office

Sarbanes Oxley USA Patriot Act SEC Loan Commitment Accounting Terrorism Risk Insurance S. 467, H.R. 4314, H.R. 4619 Natural Catastrophe Risk Insurance FAS 140 - Servicer Discretion Department of Treasury Securities Exchange Commission CRE Lending Guidance FASB Regulations Implementing Financial Aset Securitization Investment Trust Provisions Regulations Implementing the Financial Services Modernization Act

Client expense: $1,283,630 · Firm income: Not reported

Government targets: Army, Dept of (Corps of Engineers), Environmental Protection Agency (EPA), Federal Communications Commission (FCC), Federal Reserve System, HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), Interior, Dept of (DOI), Justice, Dept of (DOJ), Labor, Dept of (DOL), SENATE, Treasury, Dept of, White House Office

S. 1644, Homeland Security Appropriations Act, drug importation provisions H. Con. Res. 99, Budget Resolution, drug importation and comparative effectiveness provisions S. Con. Res. 21, Budget Resolution, drug importation and comparative effectiveness provisions S. 467, FACT Act, clinical trials and drug safety provisions S. 596, Safe Internet Pharmacy Act of 2007, clinical trials and drug safety provisions S. 484, Enhancing Drug Safety and Innovation Act of 2007, clinical trials and drug safety provisions S. 993, Pediatric Research Improvement Act, clinical trials and drug safety provisions S. 1024, Safer DATA Act, clinical trials and drug safety provisions H. R. 1561, Enhancing Drug Safety and Innovation Act of 2007, PDUFA and drug safety S. 1082, Prescription Drug User Fee Amendments of 2007, PDUFA and drug safety H. R. 2900, Food and Drug Administration Amendments Act of 2007, PDUFA and drug safety S. 623, Access to Life-Saving Medicine Act, follow-on biologics H. R. 1038, Access to Life-Saving Medicine Act, follow-on biologics H. R. 1956, Patient Protection and Innovative Biologic Medicines Act of 2007, follow-on biologics S. 1505, Affordable Biologics for Consumers Act of 2007, follow-on biologics S. 1695, Biologics Price Competition and Innovation Act of 2007, follow-on biologics S. 1156, Best Pharmaceuticals for Children Amendments of 2007, pediatric exclusivity provisions in FDARA/PDUFA bill S. 242, Pharmaceutical Market Access and Drug Safety Act of 2007, drug importation provisions S. 1745, Commerce, Justice, Science, and Related Agencies Appropriations Act, DEA drug importation language H. R. 2638, Homeland Security Appropriations Act, drug importation provisions

Client expense: Not reported · Firm income: $100,000

Government targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Patent & Trademark Office (PTO), SENATE

S. 4, Improving America's Security Act of 2007, cargo-screening provision S. 467, FACT Act, clinical trials/drug safety provisions S. 596, Safe Internet Pharmacy Act of 2007, clinical trials/drug safety provisions S. 484, Enhancing Drug Safety and Innovation Act of 2007, clinical trials/drug safety provisions S. 993, Pediatric Research Improvement Act, clinical trials/drug safety provisions S. 1024, Safer DATA Act, clinical trials/drug safety provisions H. R. 1561, Enhancing Drug Safety and Innovation Act of 2007, PDUFA, drug safety provisions S. 1082, Prescription Drug User Fee Amendments of 2007, PDUFA, drug safety provisions H. R. 2900, Food and Drug Administration Amendments Act of 2007, PDUFA, drug safety provisions S. 623, Access to Life-Saving Medicine Act, follow-on biologics H. R. 1038, Access to Life-Saving Medicine Act, follow-on biologics H. R. 1956, Patient Protection and Innovative Biologic Medicines Act of 2007, follow-on biologics S. 1505, Affordable Biologics for Consumers Act of 2007, follow-on biologics S. 1695, Biologics Price Competition and Innovation Act of 2007, follow-on biologics S. 1156, Best Pharmaceuticals for Children Amendments of 2007, pediatric exclusivity provisions in FDARA/PDUFA bill S. 242, Pharmaceutical Market Access and Drug Safety Act of 2007, drug importation provisions H. Con. Res. 99, Budget Resolution, drug importation and comparative effectiveness provisions S. Con. Res. 21, Budget Resolution, drug importation and comparative effectiveness provisions H. R. 1, Implementing the 9/11 Commission Recommendations Act of 2007, cargo-screening provision

Client expense: Not reported · Firm income: $80,000

Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Patent & Trademark Office (PTO), SENATE

All issues related to Travel/Tourism, Katrina Tax Relief, H.R. 3162/ S. 298, S. 595, H.R. 1272, S. 467, H.R. 1153, S. 1033, H.R. 2804, FY'06 Appropriations for the Department of Labor, HHS Education and Related Agencies, Department of Commerce, Justice, and State, Department of Homeland Security.

Client expense: Not reported · Firm income: $60,000

Government targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), SENATE, State, Dept of (DOS)

Any issues related to Travel and Tourism, Katrina Tax Relief, H.R. 2804, H.R. 3162, S. 298, S. 595, H.R. 1272, S. 467, H.R. 1153, S. 1033, H.R. 2330

Client expense: Not reported · Firm income: $120,000

Government targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), SENATE, State, Dept of (DOS)

H. R. 2606, 340B Program Improvement and Integrity Act of 2007, 340 B drug price expansion S. 623, Access to Life-Saving Medicine Act, follow-on biologics H. R. 1038, Access to Life-Saving Medicine Act, follow-on biologics H. R. 1956, Patient Protection and Innovative Biologic Medicines Act of 2007, follow-on biologics S. 1505, Affordable Biologics for Consumers Act of 2007, follow-on biologics S. 1695, Biologics Price Competition and Innovation Act of 2007, follow-on biologics H. R. 1561, Enhancing Drug Safety and Innovation Act of 2007, PDUFA, drug safety provisions S. 1082, Prescription Drug User Fee Amendments of 2007, PDUFA, drug safety provisions H. R. 2900, Food and Drug Administration Amendments Act of 2007, PDUFA, drug safety provisions S. 467, FACT Act, clinical trials/drug safety provisions S. 596, Safe Internet Pharmacy Act of 2007, clinical trials/drug safety provisions S. 484, Enhancing Drug Safety and Innovation Act of 2007, clinical trials/drug safety provisions S. 993, Pediatric Research Improvement Act, clinical trials/drug safety provisions S. 1024, Safer DATA Act, clinical trials/drug safety provisions H. Con. Res. 99, Budget Resolution, drug importation, comparative effectiveness provisions S. Con. Res. 21, Budget Resolution, drug importation, comparative effectiveness provisions SCHIP (Senate), Medicare cuts to finance SCHIP expansion H. R. 3162, CHAMP Act, Medicare cuts to finance SCHIP expansion S. 1376, 340B Program Improvement and Integrity Act of 2007, 340 B drug price expansion

Client expense: Not reported · Firm income: $120,000

Government targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Patent & Trademark Office (PTO), SENATE

H. R. 3093, Departments of Commerce and Justice, Science, and Related Agencies Appropriations Act, DEA drug importation language H. R. 2642, Military Construction-VA and related Agencies Appropriations Act, diabetes care provisions S. 1645, Military Construction-VA and related Agencies Appropriations Act, diabetes care provisions H. Con. Res. 99, Budget Resolution, drug importation provisions S. Con. Res. 21, Budget Resolution, drug importation provisions S. 467, FACT Act, clinical trials/drug safety provisions S. 596, Safe Internet Pharmacy Act of 2007, clinical trials/drug safety provisions S. 484, Enhancing Drug Safety and Innovation Act of 2007, clinical trials/drug safety provisions S. 993, Pediatric Research Improvement Act, clinical trials/drug safety provisions S. 1024, Safer DATA Act, clinical trials/drug safety provisions H. R. 1561, Enhancing Drug Safety and Innovation Act of 2007, drug safety provisions S. 1082, Prescription Drug User Fee Amendments of 2007, drug safety provisions H. R. 2900, Food and Drug Administration Revitalization Act, drug safety provisions S. 623, Access to Life-Saving Medicine Act, follow-on biologics H. R. 1038, Access to Life-Saving Medicine Act, follow-on biologics H. R. 1956, Patient Protection and Innovative Biologic Medicines Act of 2007, follow-on biologics S. 1505, Affordable Biologics for Consumers Act, follow-on biologics S. 1695, Biologics Price Competition and Innovation Act of 2007, follow-on biologics S. 1156, Best Pharmaceuticals for Children Amendments of 2007, pediatric exclusivity provisions in FDARA/PDUFA bill S. 242, Pharmaceutical Market Access and Drug Safety Act of 2007, drug importation provisions S. 1745, Departments of Commerce and Justice, Science, and Related Agencies Appropriations Act, DEA drug importation language H. R. 2638, Homeland Security Appropriations Act, drug importation provisions S. 1644, Homeland Security Appropriations Act, drug importation provisions

Client expense: Not reported · Firm income: $40,000

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Patent & Trademark Office (PTO), SENATE

S. 1644 Homeland Security Appropriations Act, drug importion provisions H.Con Res. 99 Budget Resolution, drug importation and comparative effectiveness provisions S. Con. Res 21 Budget Resolution, drug imporatation and comparative effectiveness provisions S. 467, FACT Act, clinical trials and drug safety provisions S. 596, Safe Internet Pharmacy Act of 2007, clinical trials and drug safety provisions S. 484, Enhancing Drug safety and Innovation Act of 2007, clinical trials and drug safety provisions S. 993, Pediatric Research Improvement Act, clinical trials and drug safety provisions S. 1024, Safe DATA Act, clinical trials and drug safety provisions HR 1561, Enhancing Drug safety and Innovation Act of 2007, PDUFA and Drug Safety S. 1082, Prescription Drug User Fee Amendments of 2007, PDUFA and drug safety HR 2900, Food and Drug Administration Amendments Act of 2007, PDUFA and drug safety S. 623, Access to Life-Saving Medicine Act, Follow-on Biologics HR 1038, Access to Life Saving Medicine Act, follow-on Biologics HR 1956, Patient Protection and Innovative Biologic Medicines Act of 2007, Follow-on Biologics S. 1505, Affordable Biologics for Consumers Act of 2007, Follow-on Biologics S. 1695, Biologics Price Competition and Innovation Act of 2007, Follow-on Biologics S. 1156, Best Pharmaceuticals for Children Amendments of 2007, pediatric exclusivity provisions in FDARA / PDUFA Bill S. 242, Pharmaceutical Market Access and Drug Safety Act of 2007, drug importation provisions S. 1745 Commerce, Justice, Science, and Related Agencies Appropriations Act, DEA Drug importation language HR 2638, Homeland Security Appropriations Act, Drug Importation Provisions Product approval discussions with Deputy Director, Food and Drug Administration

Client expense: $920,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Patent & Trademark Office (PTO), SENATE

S. 623, Access to Life-Saving Medicine Act, follow-on biologics H.R. 1038, Access to Life-Saving Medicine Act, follow-on biologics H.R. 1956, Patient Protection and Innovative Biologic Medicines Act of 2007, follow-on biologics S. 1505, Affordable Biolgoics for Consumers Act of 2007, follow-on biologics S. 1695, Biologics Price Competition and Innovation Act of 2007, follow-on biologics H.R. 1561, Enhancing Drug Safety and Innovaction Act of 2007, PDUFA, drug safety provisions S. 1082, Prescription Drug User Fee Amendments of 2007, PDUFA, drug safety provisions H.R. 2900, Food and Drug Administratio Amendments Act of 2007, PDUFA, drug safety provisions S. 467, FACT Act, clinical trials/drug safety provisions S. 596, Safe Internet Pharmacy Act of 2007, clinical trials/drug safety provisions S. 484, Enhancing Drug Safety and Innovation Act of 2007, clinical trials/drug safety provisions S. 993, Pediatric Research Improvement Act, clinical trials/drug safety provisions S. 1024, Safer DATA Act, clinical trials/drug safety provisions H. Con. Res. 99, Budget Resolution, drug importation, comparative effectiveness provisions S. Con. Res. 21, Budget Resolution, drug importation, comparative effectiveness provisions SCHIP (Senate); Medicare cuts to finance SCHIP expansion H.R. 3162; CHAMP Act; Medicare cuts to finance SCHIP expansion S. 1376; 340B Program Improvement and Integrity Act of 2007, 340 B Drug Price Expansion H.R. 2606, 340B Proram Improvement and Intergrity Act of 2007, 340 B Drug Price Expansion

Client expense: $941,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Patent & Trademark Office (PTO), SENATE

S.1056, National Cancer Act of 2007. Discussion of definition of chemo prevention treatment. S.1710/H.R.3043, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2008. Report language regarding 340B drug pricing program and efforts to change the definition of patient. S.487/H.R.710, Living Kidney Organ Donation Clarification Act. Discussion of efforts to change the definition of valuable consideration in the National Organ and Transplant Act regarding kidney paired donations. S.467, Fair Access to Clinical Trials Act. Discussion regarding potential implementation issues and the impact on clinical research. S.1376/H.R.2606, 340B Program Improvement and Integrity Act of 2007. Discussion regarding expansion of 340B drug pricing program to inpatient hospital setting.

Client expense: $500,000 · Firm income: Not reported

Government targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Natl Science Foundation (NSF), SENATE, White House Office

S. 596, Safe Internet Pharmacy Act of 2007, clinical trials/drug safety provisions S. 484, Enhancing Drug Safety and Innovation Act of 2007, clinical trials/drug safety provisions S. 993, Pediatric Research Improvement Act, clinical trials/drug safety provisions S. 1024, Safer DATA Act, clinical trials/drug safety provisions H. R. 1561, Enhancing Drug Safety and Innovation Act of 2007, PDUFA/drug safety S. 1082, Prescription Drug User Fee Amendments of 2007, PDUFA/drug safety H. R. 2900, Food and Drug Administration Revitalization Act, PDUFA/drug safety S. 623, Access to Life-Saving Medicine Act, follow-on biologics H. R. 1038, Access to Life-Saving Medicine Act, follow-on biologics H. R. 1956, Patient Protection and Innovative Biologic Medicines Act of 2007, follow-on biologics S. 1505, Affordable Biologics for Consumers Act of 2007, follow-on biologics S. 1695, Biologics Price Competition and Innovation Act of 2007, follow-on biologics S. 1156, Best Pharmaceuticals for Children Amendmentsk, pediatric exclusivity provisions in FDARA/PDUFA bill S. 242, Pharmaceutical Market Access and Drug Safety Act of 2007, drug importation provisions H. R. 1585, National Defense Authorization Act, drug pricing provisions S. 1547, National Defense Authorization Act, drug pricing provisions S. 467, FACT Act, clinical trials/drug safety provisions

Client expense: Not reported · Firm income: $40,000

Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE